HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Masato Yoneda Selected Research
Masato Yoneda Research Topics
Disease
98
Non-alcoholic Fatty Liver Disease
03/2024 - 10/2006
52
Fibrosis (Cirrhosis)
03/2024 - 06/2005
24
Neoplasms (Cancer)
01/2024 - 09/2006
20
Liver Cirrhosis (Hepatic Cirrhosis)
03/2024 - 08/2010
20
Inflammation (Inflammations)
10/2022 - 04/2005
18
Insulin Resistance
11/2023 - 04/2005
16
Obesity
02/2023 - 01/2007
15
Alcoholic Fatty Liver
12/2021 - 04/2005
14
Liver Diseases (Liver Disease)
11/2023 - 10/2007
13
Hepatocellular Carcinoma (Hepatoma)
01/2024 - 12/2004
13
Carcinogenesis
11/2023 - 10/2007
12
Type 2 Diabetes Mellitus (MODY)
01/2021 - 06/2006
10
Hemorrhage
01/2024 - 01/2007
8
Colorectal Neoplasms (Colorectal Cancer)
10/2022 - 02/2009
7
Aberrant Crypt Foci
10/2022 - 12/2008
7
Body Weight (Weight, Body)
01/2022 - 10/2005
6
Constipation
08/2022 - 01/2018
6
Dyslipidemias (Dyslipidemia)
08/2019 - 06/2010
6
Colonic Neoplasms (Colon Cancer)
07/2009 - 04/2005
5
Fatty Liver
11/2023 - 02/2011
5
Hypertension (High Blood Pressure)
12/2022 - 12/2007
5
Gastroesophageal Reflux (GERD)
11/2020 - 09/2008
5
Infections
01/2016 - 03/2005
4
Periodontitis
11/2022 - 01/2014
4
Diabetes Mellitus
01/2022 - 12/2007
4
Pancreatic Neoplasms (Pancreatic Cancer)
11/2011 - 02/2006
3
Ascites
03/2024 - 08/2023
3
Liver Failure
10/2023 - 07/2021
3
Dysbiosis
07/2021 - 01/2018
3
Adenocarcinoma
11/2011 - 01/2011
3
Autoimmune Pancreatitis
06/2011 - 01/2010
3
Polyps
07/2010 - 01/2007
2
Hepatic Encephalopathy
01/2024 - 08/2023
2
Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction)
01/2024 - 07/2023
2
Disease Progression
07/2023 - 07/2021
2
Acute Liver Failure (Fulminant Hepatic Failure)
06/2023 - 09/2021
2
Esophageal Neoplasms (Esophageal Cancer)
06/2023 - 09/2006
Drug/Important Bio-Agent (IBA)
21
Biomarkers (Surrogate Marker)
IBA
08/2023 - 05/2007
15
Alanine Transaminase (SGPT)
IBA
11/2023 - 05/2007
13
Insulin (Novolin)
FDA Link
02/2023 - 10/2005
12
Glucose (Dextrose)
FDA Link
Generic
03/2024 - 10/2005
12
Lipids
IBA
11/2023 - 01/2007
11
Proteins (Proteins, Gene)
FDA Link
02/2024 - 01/2007
11
Triglycerides (Triacylglycerol)
IBA
11/2023 - 01/2007
10
Aspartate Aminotransferases (Aspartate Transaminase)
IBA
01/2023 - 05/2007
9
Collagen Type IV (Type IV Collagen)
IBA
03/2023 - 05/2007
9
Messenger RNA (mRNA)
IBA
10/2021 - 06/2005
8
Adiponectin
IBA
02/2023 - 01/2007
8
Protons (Proton)
IBA
12/2022 - 01/2020
8
Ferritins (Ferritin)
IBA
10/2022 - 10/2005
8
Pioglitazone (Actos)
FDA Link
01/2022 - 10/2006
8
HDL Cholesterol
IBA
01/2016 - 01/2007
7
Endotoxins
IBA
10/2022 - 07/2012
7
Capsules (Microcapsules)
IBA
01/2022 - 01/2007
7
Indicators and Reagents (Reagents)
IBA
01/2022 - 10/2005
7
LDL Cholesterol
IBA
06/2020 - 01/2007
6
Therapeutic Uses
IBA
03/2021 - 07/2012
6
PPAR gamma
IBA
12/2008 - 08/2004
5
Peroxisome Proliferator-Activated Receptors (PPAR)
IBA
03/2024 - 01/2012
5
Cholesterol
IBA
11/2023 - 01/2008
5
oxidized low density lipoprotein
IBA
06/2020 - 01/2007
5
Leptin
IBA
01/2014 - 05/2009
4
RNA (Ribonucleic Acid)
IBA
11/2023 - 10/2007
4
Bile Acids and Salts (Bile Acids)
IBA
11/2023 - 06/2020
4
elobixibat
IBA
11/2023 - 01/2020
4
Acids
IBA
10/2023 - 09/2008
4
HDL Lipoproteins
IBA
10/2022 - 01/2008
4
Transaminases (Aminotransferases)
IBA
12/2021 - 10/2007
4
nas
IBA
06/2020 - 11/2011
4
Hemoglobins (Hemoglobin)
IBA
07/2018 - 01/2008
4
Nitric Oxide (Nitrogen Monoxide)
FDA Link
12/2015 - 10/2009
4
Aspirin (Acetylsalicylic Acid)
FDA Link
Generic
10/2012 - 01/2009
4
microsomal triglyceride transfer protein
IBA
08/2012 - 09/2009
4
Ligands
IBA
11/2011 - 04/2005
3
Small Interfering RNA (siRNA)
IBA
11/2023 - 01/2007
3
Serum Albumin
IBA
04/2023 - 08/2014
3
Glucagon-Like Peptide 1 (GLP 1)
IBA
01/2022 - 03/2020
3
6- ((4- ethylphenyl)methyl)- 3',4',5',6'- tetrahydro- 6'- (hydroxymethyl)spiro(isobenzofuran- 1(3H),2'- (2H)pyran)- 3',4',5'- triol
IBA
01/2022 - 03/2020
3
Iron
IBA
01/2022 - 10/2005
3
Lubiprostone
FDA Link
07/2021 - 01/2018
3
Ethanol (Ethyl Alcohol)
IBA
07/2021 - 12/2008
3
Gemcitabine
FDA Link
04/2021 - 02/2006
3
Hypoglycemic Agents (Hypoglycemics)
IBA
06/2020 - 07/2010
3
Sitagliptin Phosphate (Januvia)
FDA Link
07/2018 - 11/2011
3
Lipopolysaccharides
IBA
02/2016 - 07/2012
3
DNA (Deoxyribonucleic Acid)
IBA
01/2016 - 05/2014
3
Choline (Choline Chloride)
IBA
02/2014 - 02/2010
3
Immunoglobulin G (IgG)
IBA
06/2011 - 12/2007
3
Ezetimibe (Zetia)
FDA Link
03/2011 - 09/2009
3
Cytoplasmic and Nuclear Receptors (Nuclear Receptors)
IBA
09/2006 - 08/2004
2
obeticholic acid
IBA
03/2024 - 06/2020
2
Sodium
IBA
03/2024 - 01/2022
2
Cholestyramine Resin (Questran)
FDA Link
Generic
11/2023 - 01/2020
2
Immune Checkpoint Inhibitors
IBA
10/2023 - 06/2023
Therapy/Procedure
28
Therapeutics
03/2024 - 12/2004
13
Drug Therapy (Chemotherapy)
03/2024 - 02/2006
8
Liver Transplantation
01/2024 - 08/2020
3
Aftercare (After-Treatment)
03/2021 - 01/2011
3
Gastrostomy
12/2014 - 01/2007
2
Palliative Care (Palliative Therapy)
03/2024 - 07/2023